WEBULL

3 Undiscovered European Gems To Consider For Your Portfolio

Simply Wall St · 1d ago

As European markets navigate a landscape marked by mixed returns and fluctuating economic indicators, the pan-European STOXX Europe 600 Index has shown resilience, ending slightly higher amid hopes of interest rate cuts in the U.S. and UK. In this environment, identifying promising stocks involves looking for companies that not only demonstrate strong fundamentals but also have the potential to thrive despite broader market uncertainties.

Top 10 Undiscovered Gems With Strong Fundamentals In Europe

Name Debt To Equity Revenue Growth Earnings Growth Health Rating
Caisse Régionale de Crédit Agricole Mutuel Brie Picardie Société coopérative 37.61% 3.36% 6.34% ★★★★★★
Evergent Investments 3.63% 11.51% 22.05% ★★★★★☆
Grenobloise d'Electronique et d'Automatismes Société Anonyme 0.01% 7.01% -1.81% ★★★★★☆
Inmocemento 28.68% 4.15% 33.84% ★★★★★☆
Inversiones Doalca SOCIMI 13.10% 6.72% 3.11% ★★★★★☆
Dn Agrar Group NA 29.02% 36.03% ★★★★★☆
Envirotainer 43.54% 8.03% -34.33% ★★★★★☆
Practic NA 4.86% 6.64% ★★★★☆☆
Alantra Partners 11.36% -6.39% -33.69% ★★★★☆☆
MCH Group 126.04% 19.05% 60.90% ★★★★☆☆

Click here to see the full list of 311 stocks from our European Undiscovered Gems With Strong Fundamentals screener.

Here we highlight a subset of our preferred stocks from the screener.

Caisse Régionale de Crédit Agricole Mutuel Loire Haute-Loire Société coopérative (ENXTPA:CRLO)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Caisse Régionale de Crédit Agricole Mutuel Loire Haute-Loire Société coopérative offers a range of banking products and services to diverse customer segments in France, with a market cap of approximately €754.07 million.

Operations: CRLO generates revenue primarily from its local banking operations in France (€240.36 million) and leasing activities (€151.48 million). The company's business model focuses on serving a wide array of customer segments through these core financial services.

Caisse Régionale de Crédit Agricole Mutuel Loire Haute-Loire, with total assets of €15.5B and equity of €2.9B, shows a complex financial landscape. It boasts a price-to-earnings ratio of 9.4x, undercutting the broader French market's 16x, suggesting potential undervaluation. Despite earnings growing by 10.1% last year, its allowance for bad loans sits low at 79%, while non-performing loans are high at 3.1%. Total deposits stand at €11.9B against loans of €12.5B, indicating solid customer reliance for funding as liabilities are primarily low-risk sources (95%). Recent half-year net income rose to €50M from €48M the previous year.

ENXTPA:CRLO Debt to Equity as at Dec 2025
ENXTPA:CRLO Debt to Equity as at Dec 2025

Raisio (HLSE:RAIVV)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Raisio plc, along with its subsidiaries, is involved in the production and sale of food and food ingredients across Finland, the United Kingdom, Ireland, Belgium, and the Netherlands with a market capitalization of €417.76 million.

Operations: Raisio's revenue model focuses on the production and sale of food and food ingredients. The company's financial data indicates a segment adjustment of €264.40 million, which significantly impacts its reported figures.

Raisio, a notable player in the food industry, has been trading at 33.4% below its estimated fair value, presenting an intriguing opportunity. Over the past year, earnings grew by 19.7%, outpacing the industry's -6.1%. The company's debt-to-equity ratio increased to 6.5% over five years but remains manageable with more cash than total debt. Raisio's Q3 2025 results showed net income of €7.2 million compared to €4.9 million last year on sales of €56.7 million versus €59.1 million previously, reflecting improved profitability despite slightly lower revenue figures and indicating potential for future growth as projected EBIT is expected to rise in 2025.

HLSE:RAIVV Debt to Equity as at Dec 2025
HLSE:RAIVV Debt to Equity as at Dec 2025

Apotea (OM:APOTEA)

Simply Wall St Value Rating: ★★★★★★

Overview: Apotea AB (publ) operates an online pharmacy in Sweden with a market capitalization of SEK9.14 billion.

Operations: With a primary revenue stream from online retailers amounting to SEK7.09 billion, Apotea focuses on digital sales channels. The company's financial performance is influenced by its gross profit margin trends.

Apotea, a nimble player in the consumer retailing sector, has shown impressive financial health with no debt over the past five years. The company reported a 36.6% earnings growth last year, outpacing the industry average of -5.1%. Trading at 25.1% below estimated fair value suggests potential undervaluation. Recent results highlight sales of SEK 1,769 million for Q3 2025 compared to SEK 1,625 million last year and net income rising to SEK 69.6 million from SEK 56.2 million. Earnings per share stood at SEK 0.67 for the quarter, indicating solid profitability and high-quality earnings prospects ahead.

OM:APOTEA Earnings and Revenue Growth as at Dec 2025
OM:APOTEA Earnings and Revenue Growth as at Dec 2025

Turning Ideas Into Actions

Looking For Alternative Opportunities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.